QSAR Study of N-Myristoyltransferase Inhibitors of Antimalarial Agents

Malaria is a disease caused by protozoan parasites of the genus Plasmodium that affects millions of people worldwide. In recent years there have been parasite resistances to several drugs, including the first-line antimalarial treatment. With the aim of proposing new drugs candidates for the treatme...

Full description

Bibliographic Details
Main Authors: Letícia Santos-Garcia, Marco Antônio de Mecenas Filho, Kamil Musilek, Kamil Kuca, Teodorico Castro Ramalho, Elaine Fontes Ferreira da Cunha
Format: Article
Language:English
Published: MDPI AG 2018-09-01
Series:Molecules
Subjects:
Online Access:http://www.mdpi.com/1420-3049/23/9/2348
_version_ 1819261608391606272
author Letícia Santos-Garcia
Marco Antônio de Mecenas Filho
Kamil Musilek
Kamil Kuca
Teodorico Castro Ramalho
Elaine Fontes Ferreira da Cunha
author_facet Letícia Santos-Garcia
Marco Antônio de Mecenas Filho
Kamil Musilek
Kamil Kuca
Teodorico Castro Ramalho
Elaine Fontes Ferreira da Cunha
author_sort Letícia Santos-Garcia
collection DOAJ
description Malaria is a disease caused by protozoan parasites of the genus Plasmodium that affects millions of people worldwide. In recent years there have been parasite resistances to several drugs, including the first-line antimalarial treatment. With the aim of proposing new drugs candidates for the treatment of disease, Quantitative Structure–Activity Relationship (QSAR) methodology was applied to 83 N-myristoyltransferase inhibitors, synthesized by Leatherbarrow et al. The QSAR models were developed using 63 compounds, the training set, and externally validated using 20 compounds, the test set. Ten different alignments for the two test sets were tested and the models were generated by the technique that combines genetic algorithms and partial least squares. The best model shows r2 = 0.757, q2adjusted = 0.634, R2pred = 0.746, R2m = 0.716, ∆R2m = 0.133, R2p = 0.609, and R2r = 0.110. This work suggested a good correlation with the experimental results and allows the design of new potent N-myristoyltransferase inhibitors.
first_indexed 2024-12-23T19:44:30Z
format Article
id doaj.art-bbdc80730984419c88303e473cefbe4b
institution Directory Open Access Journal
issn 1420-3049
language English
last_indexed 2024-12-23T19:44:30Z
publishDate 2018-09-01
publisher MDPI AG
record_format Article
series Molecules
spelling doaj.art-bbdc80730984419c88303e473cefbe4b2022-12-21T17:33:35ZengMDPI AGMolecules1420-30492018-09-01239234810.3390/molecules23092348molecules23092348QSAR Study of N-Myristoyltransferase Inhibitors of Antimalarial AgentsLetícia Santos-Garcia0Marco Antônio de Mecenas Filho1Kamil Musilek2Kamil Kuca3Teodorico Castro Ramalho4Elaine Fontes Ferreira da Cunha5Departamento de Química, Universidade Federal de Lavras, Lavras 37200-000, BrazilDepartamento de Química, Universidade Federal de Lavras, Lavras 37200-000, BrazilDepartment of Chemistry, Faculty of Science, University of Hradec Kralove, Hradec Kralove 50005, Czech RepublicDepartment of Chemistry, Faculty of Science, University of Hradec Kralove, Hradec Kralove 50005, Czech RepublicDepartamento de Química, Universidade Federal de Lavras, Lavras 37200-000, BrazilDepartamento de Química, Universidade Federal de Lavras, Lavras 37200-000, BrazilMalaria is a disease caused by protozoan parasites of the genus Plasmodium that affects millions of people worldwide. In recent years there have been parasite resistances to several drugs, including the first-line antimalarial treatment. With the aim of proposing new drugs candidates for the treatment of disease, Quantitative Structure–Activity Relationship (QSAR) methodology was applied to 83 N-myristoyltransferase inhibitors, synthesized by Leatherbarrow et al. The QSAR models were developed using 63 compounds, the training set, and externally validated using 20 compounds, the test set. Ten different alignments for the two test sets were tested and the models were generated by the technique that combines genetic algorithms and partial least squares. The best model shows r2 = 0.757, q2adjusted = 0.634, R2pred = 0.746, R2m = 0.716, ∆R2m = 0.133, R2p = 0.609, and R2r = 0.110. This work suggested a good correlation with the experimental results and allows the design of new potent N-myristoyltransferase inhibitors.http://www.mdpi.com/1420-3049/23/9/2348malariaN-myristoyltransferasedrug developmentQSARmosquito-borne protozoal infection
spellingShingle Letícia Santos-Garcia
Marco Antônio de Mecenas Filho
Kamil Musilek
Kamil Kuca
Teodorico Castro Ramalho
Elaine Fontes Ferreira da Cunha
QSAR Study of N-Myristoyltransferase Inhibitors of Antimalarial Agents
Molecules
malaria
N-myristoyltransferase
drug development
QSAR
mosquito-borne protozoal infection
title QSAR Study of N-Myristoyltransferase Inhibitors of Antimalarial Agents
title_full QSAR Study of N-Myristoyltransferase Inhibitors of Antimalarial Agents
title_fullStr QSAR Study of N-Myristoyltransferase Inhibitors of Antimalarial Agents
title_full_unstemmed QSAR Study of N-Myristoyltransferase Inhibitors of Antimalarial Agents
title_short QSAR Study of N-Myristoyltransferase Inhibitors of Antimalarial Agents
title_sort qsar study of n myristoyltransferase inhibitors of antimalarial agents
topic malaria
N-myristoyltransferase
drug development
QSAR
mosquito-borne protozoal infection
url http://www.mdpi.com/1420-3049/23/9/2348
work_keys_str_mv AT leticiasantosgarcia qsarstudyofnmyristoyltransferaseinhibitorsofantimalarialagents
AT marcoantoniodemecenasfilho qsarstudyofnmyristoyltransferaseinhibitorsofantimalarialagents
AT kamilmusilek qsarstudyofnmyristoyltransferaseinhibitorsofantimalarialagents
AT kamilkuca qsarstudyofnmyristoyltransferaseinhibitorsofantimalarialagents
AT teodoricocastroramalho qsarstudyofnmyristoyltransferaseinhibitorsofantimalarialagents
AT elainefontesferreiradacunha qsarstudyofnmyristoyltransferaseinhibitorsofantimalarialagents